Browse our news

The most aggressive form of blood cancer ages immune cells and drives them to exhaustion, to the point where their ability to fight the disease is significantly impaired, a new study suggests.

ntu.ac.uk/about-us/news/news-articles/2022/11/fighting-aggressive-blood-cancer-ages-and-exhausts-immune-cells,-study-shows

Scientists in Nottingham have been awarded £462,462 for the development of a vaccine for the Zika virus from £10m of UK Aid funding for research into vaccines to protect the world from deadly diseases.

ntu.ac.uk/about-us/news/news-articles/2022/02/uk-aid-funding-for-nottingham-research-to-develop-zika-virus-vaccine

A single bout of exercise triggers processes in bone cells which could help to protect against the spreading of cancer to the bones, a new study suggests.

ntu.ac.uk/about-us/news/news-articles/2021/06/exercise-prompts-cells-to-react-in-a-way-that-could-protect-against-bone-cancer-and-other-bone-related-illnesses,-research-suggests-to-react-in-a-way-that-could-protect-against-bone-cancer-and-other-bone-related-illnesses,-research-suggests

Scientists at the University of Nottingham and Nottingham Trent University are to begin clinical trials for a DNA vaccine to prevent COVID-19.

ntu.ac.uk/about-us/news/news-articles/2020/08/funding-will-allow-clinical-trials-for-covid-19-vaccine-to-begin-in-nottingham

Scientists have identified a gene which if present in certain breast cancer patients indicates how they will respond to specific therapies.

ntu.ac.uk/about-us/news/news-articles/2020/08/gene-could-guide-better-treatment-of-most-common-breast-cancer

A new blood test developed by scientists and clinicians is able to detect the presence of prostate cancer and confirm how advanced it is.

ntu.ac.uk/about-us/news/news-articles/2020/07/new-blood-test-can-confirm-prostate-cancer-and-what-stage-it-is-at

A new study will enable clinicians to identify patients with aggressive leukaemia who will not respond to chemotherapy and those who are most likely to benefit from a new immunotherapy.

ntu.ac.uk/about-us/news/news-articles/2020/06/study-paves-way-for-faster,-more-accurate-therapies-for-hard-to-treat-leukaemia-patients

Scientists at the University of Nottingham and Nottingham Trent University will contribute essential virology expertise to help develop a safe and effective vaccine to prevent COVID-19.

ntu.ac.uk/about-us/news/news-articles/2020/04/universities-in-nottingham-to-play-a-key-role-in-the-development-of-a-potential-dna-vaccine-against-covid-19

Scientists are developing a combined vaccine to fight the most deadly form of brain cancer.

ntu.ac.uk/about-us/news/news-articles/2020/02/scientists-developing-new-vaccine-approach-for-most-aggressive-brain-cancer

Scientists have discovered a gene ‘signature’, the presence of which can “significantly improve” the accuracy of assessing how badly a patient may be affected by a form of leukaemia.

ntu.ac.uk/about-us/news/news-articles/2019/07/gene-signature-reveals-the-severity-of-disease-in-patients-with-blood-cancer